How Realistic Are Caregivers' Expectations in Patients With Subacute Stroke?
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorAnkara Etlik City Hospital
About this trial
The aim of this study is to evaluate the extent to which the patient's goals and the physical therapist's goals can be achieved after stroke rehabilitation and to compare their expectations in terms of rehabilitation outcomes. Thus, the expected benefit of the study is to contribute to goal setting in post-stroke rehabilitation. There are no expected risks from the study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Followed by ischemic or hemorrhagic stroke
No more than 6 months have passed since the date of the event
Being between the ages of 18 and 75
The caregiver being between the ages of 18 and 75
Disqualifiers
The patient has additional neurological conditions besides stroke
The patient has a psychiatric condition
The patient is not willing to participate in the study
Trial population
Fifty-eight stroke patients receiving inpatient treatment at the Ankara Etlik City Hospital Brain Injury-3 clinic and their caregivers will be evaluated.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Conventional rehabilitation programme
Other interventionConventional rehabilitation programme described for patients individually
Treatment groups
58 Participants
are divided into 1 treatment groupGroup A: Stoke Patients1 intervention
Trial outcomes
Primary outcomes
1
Goal Attainment Scale
The Goal Attainment Scale will be used as the primary outcome measure within the framework of goals set separately by the caregiver and the physical therapist.
Time frame
First day of rehabilitation, 4th week of rehabilitationSecondary outcomes
1
Functional Ambulation Scale
Time frame
First day of rehabilitation, 4th week of rehabilitation2
Modified Barthel Index
Time frame
First day of rehabilitation, 4th week of rehabilitationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov